TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 SEK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
14,799
|
12,678
|
11,834 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
678
|
333
|
317 |
EBITDA |
896
|
538
|
325 |
Total assets |
6,187
|
5,129
|
4,695 |
Current assets |
5,496
|
4,315
|
4,667 |
Current liabilities |
1,998
|
1,466
|
1,310 |
Equity capital |
3,942
|
3,412
|
3,154 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
4
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
63.7%
|
66.5%
|
67.2% |
Turnover per employee |
3,700
|
4,226
|
3,945 |
Profit as a percentage of turnover |
4.6%
|
2.6%
|
2.7% |
Return on assets (ROA) |
11.0%
|
6.5%
|
6.8% |
Current ratio |
275.1%
|
294.3%
|
356.3% |
Return on equity (ROE) |
17.2%
|
9.8%
|
10.1% |
Change turnover |
2,121
|
844
|
103 |
Change turnover % |
17%
|
7%
|
1% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.